Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy

[1]  Jagmeet P. Singh,et al.  Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial , 2016, European heart journal.

[2]  C. Rinaldi,et al.  In Heart Failure Patients with Left Bundle Branch Block Single Lead MultiSpot Left Ventricular Pacing Does Not Improve Acute Hemodynamic Response To Conventional Biventricular Pacing. A Multicenter Prospective, Interventional, Non-Randomized Study , 2016, PloS one.

[3]  N. Peters,et al.  Atrioventricular delay optimization of cardiac resynchronisation therapy: comparison of non-invasive blood pressure with invasive haemodynamic measures. , 2015, International journal of cardiology.

[4]  J. Brugada,et al.  Effect of Study Design on the Reported Effect of Cardiac Resynchronization Therapy (CRT) on Quantitative Physiological Measures: Stratified Meta‐Analysis in Narrow‐QRS Heart Failure and Implications for Planning Future Studies , 2015, Journal of the American Heart Association.

[5]  A. Hughes,et al.  British randomised controlled trial of AV and VV optimization (“BRAVO”) study: rationale, design, and endpoints , 2014, BMC Cardiovascular Disorders.

[6]  Robert G. Turcott,et al.  Cardiac resynchronisation therapy optimisation strategies: systematic classification, detailed analysis, minimum standards and a roadmap for development and testing. , 2013, International journal of cardiology.

[7]  K. Ellenbogen,et al.  Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: Implications for clinical trial design and clinical practice☆☆☆ , 2013, International journal of cardiology.

[8]  A. Hughes,et al.  Multinational evaluation of the interpretability of the iterative method of optimisation of AV delay for CRT. , 2013, International journal of cardiology.

[9]  David O. Martin,et al.  Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial. , 2013, Heart rhythm.

[10]  Jeroen J. Bax,et al.  Effect of atrioventricular and ventriculoventricular delay optimization on clinical and echocardiographic outcomes of patients treated with cardiac resynchronization therapy: a meta-analysis. , 2013, American heart journal.

[11]  Luigi Padeletti,et al.  A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Heart rhythm.

[13]  A. Hughes,et al.  The Acute Effects of Changes to AV Delay on BP and Stroke Volume: Potential Implications for Design of Pacemaker Optimization Protocols , 2012, Circulation. Arrhythmia and electrophysiology.

[14]  D. Francis.  Precision of a Parabolic Optimum Calculated from Noisy Biological Data, and Implications for Quantitative Optimization of Biventricular Pacemakers (Cardiac Resynchronization Therapy) , 2011 .

[15]  Suneet Mittal,et al.  Primary Results From the SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV) Trial: A Randomized Trial Comparing Empirical, Echocardiography-Guided, and Algorithmic Atrioventricular Delay Programming in Cardiac Resynchron , 2010, Circulation.

[16]  G. Maurer,et al.  Electrical optimization of cardiac resynchronization in chronic heart failure is associated with improved clinical long‐term outcome , 2010, European journal of clinical investigation.

[17]  Manish S. Gupta,et al.  Optimization of AV and VV Delays in the Real‐World CRT Patient Population: An International Survey on Current Clinical Practice , 2009, Pacing and clinical electrophysiology : PACE.

[18]  R. Arena,et al.  The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review , 2008, Heart Failure Reviews.

[19]  J. Daubert,et al.  Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. , 2006, European heart journal.

[20]  A. Hughes,et al.  Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay , 2006, Heart.

[21]  Jamil Mayet,et al.  Determination of optimal atrioventricular delay for cardiac resynchronization therapy using acute non-invasive blood pressure. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[23]  J. Schroeder,et al.  Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.

[24]  A. Waggoner,et al.  Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. , 2004, Heart rhythm.

[25]  Albert Meijer,et al.  Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. , 2004, The American journal of cardiology.

[26]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[27]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[28]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[29]  E Fleck,et al.  Effect of Resynchronization Therapy Stimulation Site on the Systolic Function of Heart Failure Patients , 2001, Circulation.

[30]  N Freemantle,et al.  The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points , 2001, European journal of heart failure.

[31]  M. Piepoli,et al.  Validation of a treadmill exercise test protocol with improved metabolic plateau formation in patients with chronic congestive heart failure. , 2001, The American journal of cardiology.

[32]  Gregory S. Nelson,et al.  Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block , 2000, Circulation.

[33]  Andrew P. Kramer,et al.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. , 1999, Circulation.

[34]  J. Blanc,et al.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.

[35]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.

[36]  Christophe Leclercq,et al.  2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[37]  Q. Fang,et al.  [Combined cardiac resynchronization and implantable cardioversion defibrillation]. , 2005, Zhonghua xin xue guan bing za zhi.

[38]  A. Auricchio,et al.  Acute effects of cardiac resynchronization therapy on left ventricular Doppler indices in patients with congestive heart failure. , 2002, American heart journal.

[39]  C. Jenkinson,et al.  Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). , 1997, Age and ageing.